AU2023313342A1 - 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents - Google Patents

1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents Download PDF

Info

Publication number
AU2023313342A1
AU2023313342A1 AU2023313342A AU2023313342A AU2023313342A1 AU 2023313342 A1 AU2023313342 A1 AU 2023313342A1 AU 2023313342 A AU2023313342 A AU 2023313342A AU 2023313342 A AU2023313342 A AU 2023313342A AU 2023313342 A1 AU2023313342 A1 AU 2023313342A1
Authority
AU
Australia
Prior art keywords
hydroxy
methyl
methylene
bis
phenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023313342A
Other languages
English (en)
Inventor
Zsolt Baranyai
Mariangela BOCCALON
Mauro Botta
Fabio Carniato
Lorenzo Tei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Imaging SpA
Original Assignee
Bracco Imaging SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging SpA filed Critical Bracco Imaging SpA
Publication of AU2023313342A1 publication Critical patent/AU2023313342A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2023313342A 2022-07-28 2023-07-28 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents Pending AU2023313342A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22187403.5 2022-07-28
EP22187403 2022-07-28
PCT/EP2023/071027 WO2024023314A1 (en) 2022-07-28 2023-07-28 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents

Publications (1)

Publication Number Publication Date
AU2023313342A1 true AU2023313342A1 (en) 2024-12-19

Family

ID=82780974

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023313342A Pending AU2023313342A1 (en) 2022-07-28 2023-07-28 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents

Country Status (10)

Country Link
US (1) US12358880B2 (cg-RX-API-DMAC7.html)
EP (1) EP4561995B1 (cg-RX-API-DMAC7.html)
JP (1) JP2025524769A (cg-RX-API-DMAC7.html)
KR (1) KR20250040575A (cg-RX-API-DMAC7.html)
CN (1) CN119343336A (cg-RX-API-DMAC7.html)
AU (1) AU2023313342A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252691A1 (cg-RX-API-DMAC7.html)
IL (1) IL317339A (cg-RX-API-DMAC7.html)
MX (1) MX2024015341A (cg-RX-API-DMAC7.html)
WO (1) WO2024023314A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025163025A1 (en) 2024-01-31 2025-08-07 Bracco Imaging Spa Pyridophane macrocyclic ligands and fe(iii) complexes thereof
CN119499407B (zh) * 2024-11-25 2026-04-07 中国科学院精密测量科学与技术创新研究院 一种Fe基T7肽靶向脑胶质瘤小分子磁共振造影剂及其制备合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3624859A4 (en) 2017-05-19 2021-03-03 The Research Foundation for The State University of New York COMPOUNDS FOR USE AS IRON (III) MRT CONTRAST AGENTS
EP3880635B1 (en) 2018-11-12 2023-01-04 Bracco Imaging SPA Chelating aazta conjugate, complexes thereof and use

Also Published As

Publication number Publication date
IL317339A (en) 2025-01-01
JP2025524769A (ja) 2025-08-01
EP4561995B1 (en) 2026-05-27
WO2024023314A1 (en) 2024-02-01
US20250163007A1 (en) 2025-05-22
EP4561995A1 (en) 2025-06-04
US12358880B2 (en) 2025-07-15
CA3252691A1 (en) 2024-02-01
EP4561995C0 (en) 2026-05-27
CN119343336A (zh) 2025-01-21
KR20250040575A (ko) 2025-03-24
MX2024015341A (es) 2025-02-10

Similar Documents

Publication Publication Date Title
US11357873B2 (en) Chiral cyclen compounds and their uses
WO2024023314A1 (en) 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents
KR20210041566A (ko) 가돌리늄 함유 pcta-기반 조영제
Nocton et al. Water Stability and Luminescence of Lanthanide Complexes of Tripodal Ligands Derived from 1, 4, 7‐Triazacyclononane: Pyridinecarboxamide versus Pyridinecarboxylate Donors
SI8810742A (en) Process for the preparation of the new nitrogen-containing cyclic ligands,metallic complexes formed by these ligands and diagnostic composition containing these complexes.
Chalmers et al. Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance
Wong et al. Hexadentate N4O2 amine phenol complexes of gallium and indium
Gugliotta et al. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents
CN110944676A (zh) 用作铁(iii)mri造影剂的化合物
EP2920156B9 (en) Process for the preparation of macrocyclic polyazacarboxylate ligands and chelates
US12077520B2 (en) Compounds for the selective solid-liquid extraction and liquid-liquid extraction of lithium chloride
US20240228524A1 (en) Iron(iii) macrocyclic complexes with mixed hyroxyl pendants as mri contrast agents
US20140323717A1 (en) Methods for Preparing Functional Tetraazacycloalkane Compounds using a Specific Cyclic Bisaminal Compound
Costero et al. Synthesis of a new allosteric carrier containing three conformationally related subunits
Lei et al. Synthesis of bifunctional biscatecholamine chelators for uranium decorporation
Motekaitis et al. Synthesis, characterization, and Cu (II) solution chemistry of dioxotetraazamacrocycles
WO2025120059A1 (en) Compound for disorders associated with excess and/or accumulation of iron ions
HK40118708A (en) 1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(iii) complexes for use as mri contrast agents
Dickins et al. A new chiral lanthanide NMR probe for the determination of the enantiomeric purity of α-hydroxy acids and the absolute configuration of α-amino acids in water
US20110021765A1 (en) Fluorinated lanthanide probes for 19f magnetic resonance applications
Alekseeva et al. p-tert-Butylcalix [4] arenes containing azacrown ether substituents at the lower rim as potential polytopic receptors
WO2025163025A1 (en) Pyridophane macrocyclic ligands and fe(iii) complexes thereof
Albrecht et al. Decorating the lanthanide terminus of self-assembled heterodinuclear lanthanum (iii)/gallium (iii) helicates
US20240199588A1 (en) Chiral TACN/NOTA compounds/derivatives with and without metals for application
Michaudet et al. Pre-shaped aromatic picket porphyrins bearing neutral oxygen donors and their bismuth complexes: Synthesis and coordination studies